Bayer, Merck KGaA Sue Actavis Claiming Patent Violation

Bayer AG and a Merck KGaA unit sued Actavis Inc. in Delaware over a planned generic version of the birth-control drug Safyral.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.